Moving Stocks: ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), Aratana Therapeutics, Inc. (NASDAQ:PETX), CommunityOne Bancorp (NASDAQ:COB), CH Robinson Worldwide Inc.

ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV) reported a positive outcome from an important drug-drug interaction study regarding the Company’s novel antiviral drug candidate FV-100, which is currently in Phase 3 clinical development to prevent the debilitating shingles-associated pain known as post-herpetic neuralgia (PHN).

ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV) belongs to Healthcare sector. Its weekly performance is 3.63%. On last trading day company shares ended up at $0.96. ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV) distance from 50-day simple moving average (SMA50) is 0.61%.

Aratana Therapeutics, Inc. (NASDAQ:PETX) said that, it plans to present at the Barclays Capital Global Healthcare Conference on Wednesday, March 16 at 3:50 p.m. ET in Miami at the Loews Miami Beach Hotel.

Aratana Therapeutics, Inc. (NASDAQ:PETX) shares advanced 2.02% in last trading session and ended the day at $4.04. PETX Gross Margin is 11.10% and its return on assets is -45.20%. Aratana Therapeutics, Inc. (NASDAQ:PETX) quarterly performance is -32.21%.

Private Management Group Inc. lowered its position in CommunityOne Bancorp (NASDAQ:COB) by 55.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC.

On 04 March, CommunityOne Bancorp (NASDAQ:COB) shares decreased -0.46% and was closed at $12.97. COB EPS growth in last 5 year was 15.00%. CommunityOne Bancorp (NASDAQ:COB) year to date (YTD) performance is -3.71%.

C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) announced a quarterly dividend. Investors of record on Friday, March 4th will be given a dividend of 0.43 per share on Thursday, March 31st.

CH Robinson Worldwide Inc. (NASDAQ:CHRW) ended the last trading day at $72.68. Company weekly volatility is calculated as 1.91% and price to cash ratio as 61.89. CH Robinson Worldwide Inc. (NASDAQ:CHRW) showed a weekly performance of 3.94%.

On 25 February, EMCOR Group Inc. (NYSE:EME) reported results for the fourth quarter and the year ended December 31, 2015. For the fourth quarter of 2015, net income from continuing operations attributable to EMCOR was $50.4 million, or $0.80 per diluted share, compared to $43.1 million, or $0.66 per diluted share, in the fourth quarter of 2014.

EMCOR Group Inc. (NYSE:EME) shares decreased -1.76% in last trading session and ended the day at $47.34. EME Gross Margin is 14.10% and its return on assets is 5.00%. EMCOR Group Inc. (NYSE:EME) quarterly performance is -7.94%.

Leave a Reply

Your email address will not be published. Required fields are marked *